Clinical Trials in North Carolina

Showing 10821-10840 of 15,496 trials

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

NCT02131324

The purpose of this study is to evaluate the potential of DFD06 cream to suppress the HPA (hypothalamic-pituitary-adrenal) axis as compared to clobetasol propionate cream, 0.05% cream when applied twice daily for 15 days.

Psoriasis

Promius Pharma, LLC50 participantsStarted May 2014

Glendale, Arizona, United States • Mesa, Arizona, United States • Encino, California, United States +12 more locations

COMPLETEDPhase 338 miles

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

NCT02284893

Study will evaluate if a combination of saxagliptin and dapagliflozin added concurrently to metformin in combination with diet and exercise is superior to sitagliptin added to metformin in combination with diet and exercise in reducing mean HbA1c over a treatment period of 26 weeks.

Type 2 Diabetes

AstraZeneca461 participantsStarted Sep 2014

Mesa, Arizona, United States • Mesa, Arizona, United States • Phoenix, Arizona, United States +76 more locations

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Find Trials by Condition in North Carolina

Early Mobility for the Critically Injured Burn Patient

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

ATLAS: Ambulatory Treatments for Leakage Associated With Stress

A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

Evaluation of a Commercial Program on Weight Loss and Health Outcomes

Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

Bilateral Cochlear Implantation in Children With the MED-EL Cochlear Implant

PF-00489791 For The Treatment Of Raynaud's

Thrombolysis in Pediatric Stroke (TIPS)

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers